Thalidomide: An Overview and the Species-Specific Teratogenicity
Conclusion: Outside clinical trials, vtD remains a superior induction regimen compared with TD in transplant-eligible, newly diagnosed patients ...
16-Thalidomide and dexamethasone oral SUPERSEDED | eviQThey showed that single-agent thalidomide can induce a partial response in approximately 30% of patients with refractory myeloma. The combination of thalido-. Thalidomide for Treating Metastatic Hepatocellular CarcinomaFurthermore, the TD regimen was administered to eight patients with primary refractory myeloma who were eligible for high-dose therapy with autologous stem cell. The Thalidomide StoryThalidomide (TD) was first developed as a safe sedative hypnotic in 1958 and was prescribed for pregnant women to prevent morning sickness.
Autres Cours: